We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Single-Molecule Tethering Detects Nucleic Acids and Microorganisms

By LabMedica International staff writers
Posted on 29 Oct 2020
Detection of microbial nucleic acids in body fluids has become the preferred method for rapid diagnosis of many infectious diseases. More...
However, culture-based diagnostics that are time-consuming remain the gold standard approach in certain cases, such as sepsis.

The polymerase chain reaction (PCR) has enabled a revolution in in vitro diagnostics due to its sensitivity and specificity. However, polymerase-based methodologies require complex sample preparation steps to remove polymerase inhibitors in certain specimen types, and relatively expensive reagents and instrumentation.

A team of scientists at the biotechnology company Scanogen (Windsor Mill, MD, USA) collected data from 200 tests run on normal samples spiked with known concentrations of pathogen. The team used a technology called single-molecule tethering (SMOLT) that generates a signal when micron-sized beads tethered by double-stranded DNA probes inside a capillary are displaced in the presence of a target pathogen.

Beads tethered by a probe can be differentiated from beads that are not specific to the target of interest because the long-probe tethered beads are displaced by a greater distance. The displacement is determined by processing images obtained with a low-magnification lens and a low-cost digital camera.

The team reported that SMOLT technology can detect RNA molecules in whole blood, urine, and sputum. The technology also detected Candida species and two bacterial species, Staphylococcus aureus and Pseudomonas aeruginosa, in whole blood. The limits of detection was between 1 and 3 colony forming unit per milliliter (CFU/mL), comparable to current PCR tests on the market. The technology also readily lends itself to multiplexing that would enable identification of up to 20 targets per test run.

The team showed that SMOLT detection of microbial ribosomal ribonucleic acid (rRNA) enables high sensitivity with a turnaround time from sample to results of 1.5 hours. They designed species-specific probes that targeted the rRNA of the two most prevalent sepsis-causing fungi, Candida albicans and Candida glabrata, as well as pan-fungal probes that targeted highly conserved regions in fungal rRNA using a local database of microbial and human rRNA sequences.

For clinical testing in a laboratory, the company envisions that its future customers will be able to stack testing modules on top of each other. An eight-module stack, with each module running tests for up to 20 pathogens, will cost about USD 50,000, Celedon said, adding that the price is significantly lower than the instruments with which it intends to complete.

Alfredo Celedon, the founder of Scanogen and CEO, said “The firm anticipates offering pricing to laboratories at between USD 20 and USD 50 per test, while competing multiplexed tests are priced at USD 200 or more per test. For clinical testing in a laboratory, the company envisions that its future customers will be able to stack testing modules on top of each other. The study was published on September 22, 2020 in the journal Nature Communications.

Related Links:
Scanogen



Gold Member
Cardiovascular Risk Test
Metabolic Syndrome Array I & II
Collection and Transport System
PurSafe Plus®
8-Channel Pipette
SAPPHIRE 20–300 µL
ESR Analyzer
TEST1 2.0
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Hematology

view channel
Image: New evidence shows viscoelastic testing can improve assessment of blood clotting during postpartum hemorrhage (Photo courtesy of 123RF)

Viscoelastic Testing Could Improve Treatment of Maternal Hemorrhage

Postpartum hemorrhage, severe bleeding after childbirth, remains one of the leading causes of maternal mortality worldwide, yet many of these deaths are preventable. Standard care can be hindered by delays... Read more

Immunology

view channel
Image: The CloneSeq-SV approach can allow researchers to study how cells within high-grade serous ovarian cancer change over time (Photo courtesy of MSK)

Blood Test Tracks Treatment Resistance in High-Grade Serous Ovarian Cancer

High-grade serous ovarian cancer (HGSOC) is often diagnosed at an advanced stage because it spreads microscopically throughout the abdomen, and although initial surgery and chemotherapy can work, most... Read more

Industry

view channel
Image: The collaboration aims to improve access to Hb variant testing with the Gazelle POC diagnostic platform (Photo courtesy of Hemex Health)

Terumo BCT and Hemex Health Collaborate to Improve Access to Testing for Hemoglobin Disorders

Millions of people worldwide living with sickle cell disease and other hemoglobin disorders experience delayed diagnosis and limited access to effective care, particularly in regions where testing is scarce.... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.